| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 6e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.21 | 5e-05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |